-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
-
US races to secure rare earths to rebuild depleted arsenal
-
Matthew Perry drug middleman jailed for two years
-
Warsh confirmed as Fed chair as central bank faces Trump assault
Vaccines facing misinformation spike: WHO experts
Vaccine programmes are being challenged by rising misinformation and an uncertain pipeline for research funding, the World Health Organization's immunisation experts said Wednesday.
And the war in the Middle East will likely hamper the fight against polio, the WHO's Strategic Advisory Group of Experts on Immunisation (SAGE) said.
The group held its biannual meeting last week, focusing on Covid-19 jab recommendations, typhoid vaccine dosing schedules and oral polio vaccine doses in routine immunisation.
"Emerging challenges for the future include uncertain funding for vaccine research and development, and misinformation and distorted information that erodes public trust in vaccines," said SAGE.
"Protecting trust and countering misinformation will be a central focus in 2026."
WHO vaccines chief Kate O'Brien said resources would be targeted this year on protecting the roll-out of core immunisation programmes.
"We're in a really deeply changing world for infectious diseases and for vaccine programmes," she said, due to conflicts, economic challenges and health budgets being cut.
Trust in vaccines is being "threatened by misinformation", she told a press conference.
Robert F. Kennedy Jr, the US health chief, has long voiced anti-vaccine rhetoric and inaccurate claims connecting vaccines and autism.
A WHO review of all available evidence issued in December reaffirmed there is no link between vaccines and autism -- contrary to the theories being propagated in the United States and beyond.
"Vaccines do not cause autism and they never have caused autism," stressed O'Brien.
She said vaccines had saved 154 million lives over the past 50 years, and more than 30 diseases could be prevented through immunisation.
"The risk is about backsliding, or even countries deciding that they can't afford all of the vaccines that are in their programme," she said.
- Crisis and response cycle -
The group voiced concern over the ongoing transmission of wild poliovirus in Pakistan and Afghanistan, and the persistent detection of vaccine-derived type-2 poliovirus in several African countries, a strain related to the weakened live poliovirus contained in oral polio vaccines.
"The conflict in the Middle East may well lead to further dissemination of polioviruses, which would then add to the burden to be mopped up in order to reach that eradication goal," SAGE chair Anthony Scott told reporters.
O'Brien added: "There are billions and billions of dollars being spent, day in and day out to destroy lives through wars.
"Does the world have its priorities straight about what we're investing in?"
As for Covid jabs, SAGE said countries should consider routine vaccination twice a year for groups at the highest risk of severe disease, because of the dwindling protection levels beyond six months.
O'Brien said the Covid-19 vaccine market had contracted down to a limited number of manufacturers and types, with mRNA vaccines remaining the dominant form.
She called for more investment, with one priority being to develop pan-coronavirus vaccines that tackle more than just Covid-19, and longer-lasting injections to reduce the repeat jabs burden on health services and the elderly.
But research and development funding tends to follow major outbreaks, meaning "we are always in this cycle of crisis and response", she said.
SAGE executive secretary Annelies Wilder-Smith said "we really need" Covid vaccines that have bigger impact on mild disease and reducing transmission of the virus.
B.Torres--AT